FY2025 · ended Dec 31, 2025 · Revenue $56.65M, +10.4% YoY · Filed Feb 13, 2026
CVRx, Inc. (CVRX) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $56.7 million and a net loss of $53.3 million. Free cash flow was -$40.8 million. As of Jun 30, 2026 it held $64.6 million in cash and investments and $59.4 million in total debt.
Revenue (TTM)
$61.19M
+12.0% vs year-ago TTM
Net income (TTM)
$-51.97M
+0.5% vs year-ago TTM
Operating cash flow (TTM)
$-40.46M
-3.4% vs year-ago TTM
Free cash flow (TTM)
$-41.05M
-4.1% vs year-ago TTM
EPS (TTM)
$-1.97
+6.1% vs year-ago TTM
Dividend per share
None
Shares outstanding
26.31M
+1.1% vs prior year
Net cash
$5.20M
as of Jun 30, 2026
Operating margin
-79.5%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- CVRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Minneapolis, MN
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1235912
- Former names
- CVRX INC (until Jul 15, 2013)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $56.7M | $51.3M | $39.3M | $22.5M | $13.0M |
| Operating income | -$51.3M | -$59.5M | -$43.1M | -$42.5M | -$26.0M |
| Net income | -$53.3M | -$60.0M | -$41.2M | -$41.4M | -$43.1M |
| Diluted EPS | -$2.04 | -$2.65 | -$1.99 | -$2.02 | — |
| Operating cash flow | -$40.2M | -$39.1M | -$39.0M | -$42.7M | -$27.7M |
| Free cash flow | -$40.8M | -$40.5M | -$39.6M | -$43.4M | -$28.9M |
| Total assets | $104.8M | $133.4M | $115.2M | $124.9M | $152.5M |
| Total liabilities | $65.5M | $62.4M | $39.3M | $15.8M | $6.6M |
| Stockholders' equity | $39.3M | $71.1M | $75.9M | $109.2M | $146.0M |
| Cash and investments | $75.7M | $105.9M | $90.6M | $106.2M | $142.1M |
| Total debt | $50.5M | $50.4M | $30.6M | $7.1M | $0 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Sep 21, 2026 | Sep 16, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 11, 2026 | Aug 10, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 9, 2026 | Jun 7, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2026 | Jun 1, 2026 |
All 345 CVRx, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.